Functional imaging of the liver.
暂无分享,去创建一个
[1] Jürgen Hennig,et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. , 2005, European journal of cancer.
[2] J. van der Grond,et al. 31P magnetic resonance spectroscopy of the liver: Correlation with standardized serum, clinical, and histological changes in diffuse liver disease , 1995, Hepatology.
[3] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[4] P. Robinson,et al. Hepatic perfusion index and the evolution of liver metastases. , 1987, Nuclear medicine communications.
[5] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[6] Y. Kuo,et al. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0‐T MR scanner , 2004, Journal of magnetic resonance imaging : JMRI.
[7] L. Boussel,et al. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. , 2012, Magnetic resonance imaging.
[8] Noriyuki Moriyama,et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. , 2011, Radiology.
[9] C. Tiribelli,et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.
[10] A. Manduca,et al. Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] Y. Ohno,et al. Perfusion measurement of the whole upper abdomen of patients with and without liver diseases: initial experience with 320-detector row CT. , 2012, European journal of radiology.
[12] R. Ehman,et al. MR elastography of liver tumors: preliminary results. , 2008, AJR. American journal of roentgenology.
[13] Ting-Yim Lee,et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. , 2003, AJNR. American journal of neuroradiology.
[14] Takeo Ishigaki,et al. Diffusion‐weighted images of the liver: Comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide , 2005, Journal of magnetic resonance imaging : JMRI.
[15] D. Collins,et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases , 2013, European Radiology.
[16] F. Fazio,et al. Perfusion Computed Tomographic Assessment of Early Hepatocellular Carcinoma in Cirrhotic Liver Disease: Initial Observations , 2008, Journal of computer assisted tomography.
[17] K. Miles,et al. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. , 1997, Radiology.
[18] C. Charnsangavej,et al. Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. , 2005, Radiology.
[19] A. Vaccarino,et al. Estimation of hepatic arterial and portal venous blood flow by direct catheterization of the vena porta through the umbilical cord in man. Preliminary results. , 1968, Acta hepato-splenologica.
[20] Michael J Paldino,et al. Fundamentals of quantitative dynamic contrast-enhanced MR imaging. , 2009, Magnetic resonance imaging clinics of North America.
[21] Stephanie R Wilson,et al. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? , 2009, AJR. American journal of roentgenology.
[22] D L Buckley,et al. Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix , 2009, British Journal of Cancer.
[23] O. Matsui,et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis , 2011, Abdominal Imaging.
[24] U. Motosugi,et al. MRI‐based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion‐weighted imaging with magnetic resonance elastography , 2015, Journal of magnetic resonance imaging : JMRI.
[25] Eun Sun Lee,et al. MR elastography for noninvasive assessment of hepatic fibrosis: Reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement , 2014, Journal of magnetic resonance imaging : JMRI.
[26] M. Reiser,et al. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. , 2012, Radiology.
[27] Zhongwei Qiao,et al. Liver fibrosis: An intravoxel incoherent motion (IVIM) study , 2012, Journal of magnetic resonance imaging : JMRI.
[28] Panagiotis Samaras,et al. Quantitative Perfusion Analysis of Malignant Liver Tumors: Dynamic Computed Tomography and Contrast-Enhanced Ultrasound , 2012, Investigative radiology.
[29] N. Holalkere,et al. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. , 2008, The oncologist.
[30] R. Constable,et al. Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations--preliminary MR imaging in rats. , 2008, Radiology.
[31] Ting-Yim Lee,et al. Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study , 2008, Physics in medicine and biology.
[32] Isamu Ohashi,et al. Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis , 2005, Journal of magnetic resonance imaging : JMRI.
[33] A. Padhani,et al. Multiparametric imaging of tumor response to therapy. , 2010, Radiology.
[34] B. Taouli,et al. Diffusion-weighted MR imaging of the liver. , 2010, Radiology.
[35] N. Holalkere,et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. , 2007, Radiology.
[36] H. Rusinek,et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. , 2008, Radiology.
[37] M. Lupsor,et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis , 2012, Journal of viral hepatitis.
[38] M. Prokop. CT and MR to assess the response of liver tumors to hepatic perfusion. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[39] Hatem Alkadhi,et al. Quantification of Liver Fat in the Presence of Iron and Iodine: An Ex-Vivo Dual-Energy CT Study , 2011, Investigative radiology.
[40] M. Lindstrom,et al. Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects , 2011, Journal of magnetic resonance imaging : JMRI.
[41] F. Pilleul,et al. Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion. , 2010, World journal of radiology.
[42] B. V. Van Beers,et al. Liver fibrosis: non‐invasive assessment with MR elastography , 2006, NMR in biomedicine.
[43] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[44] C. Thng,et al. Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling , 2009, European Radiology.
[45] Peter N. Burns,et al. Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. , 2011, Radiology.
[46] D. Collins,et al. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. , 2012, The British journal of radiology.
[47] B. Choi,et al. Evaluation of Hepatic Fibrosis Using Intravoxel Incoherent Motion in Diffusion-Weighted Liver MRI , 2014, Journal of computer assisted tomography.
[48] D. Menon,et al. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. , 1995, Gastroenterology.
[49] E. Scurr,et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination , 2008, European Radiology.
[50] M. Cova,et al. Blood Flow Changes in Hepatocellular Carcinoma After the Administration of Thalidomide Assessed by Reperfusion Kinetics During Microbubble Infusion: Preliminary Results , 2006, Investigative radiology.
[51] Ralph Sinkus,et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. , 2007, Radiology.
[52] G. Gerken,et al. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients , 2010, Transplantation.
[53] A. Padhani,et al. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology. , 2010, Magnetic resonance imaging clinics of North America.
[55] A K Dixon,et al. Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.
[56] Celia P. Corona-Villalobos,et al. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. , 2013, AJR. American journal of roentgenology.
[57] Aya Kamaya,et al. CT perfusion of the liver: principles and applications in oncology. , 2014, Radiology.
[58] D. Radice,et al. Perfusion Computed Tomography in Patients With Hepatocellular Carcinoma Treated With Thalidomide: Initial Experience , 2011, Journal of computer assisted tomography.
[59] S. Taylor-Robinson,et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study , 2003, Gut.
[60] L. Shen,et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. , 2008, Radiology.
[61] Linda Chami,et al. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. , 2011, Radiology.
[62] W W Lautt,et al. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. , 1985, The American journal of physiology.
[63] Robert Lucht,et al. Tracer kinetic analysis of signal time series from dynamic contrast-enhanced MR imaging , 2006, Biomedizinische Technik. Biomedical engineering.
[64] O. Matsui,et al. Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. , 2007, Radiology.
[65] I. Kamel,et al. An Elevated Arterial Enhancement Fraction Is Associated With Clinical and Imaging Indices of Liver Fibrosis and Cirrhosis , 2012, Journal of computer assisted tomography.
[66] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[67] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[68] H. Wittsack,et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. , 2006, AJNR. American journal of neuroradiology.
[69] X. Forns,et al. MR elastography to assess liver fibrosis. , 2008, Radiology.
[70] C. Ganter,et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique , 2008, European Radiology.
[71] Won Jae Lee,et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. , 2012, Radiology.
[72] Y. Tsushima,et al. Does the Presence of Distant and Local Malignancy Alter Parenchymal Perfusion in Apparently Disease-Free Areas of the Liver? , 2001, Digestive Diseases and Sciences.
[73] J. Hennig,et al. DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study , 2009, Journal of angiogenesis research.
[74] S. Pagnotta,et al. Comparison between CT and MR in perfusion imaging assessment of high-grade gliomas , 2013, La radiologia medica.
[75] Y. Tsushima,et al. The Portal Component of Hepatic Perfusion Measured by Dynamic CT (An Indicator of Hepatic Parenchymal Damage) , 1999, Digestive Diseases and Sciences.
[76] Emilio Quaia,et al. Assessment of tissue perfusion by contrast-enhanced ultrasound , 2011, European Radiology.
[77] J. Stoker,et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. , 2007, The British journal of radiology.
[78] L. Axel. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.
[79] Gerald Antoch,et al. Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity , 2011, European Radiology.
[80] C. Thng,et al. Perfusion imaging in liver MRI. , 2014, Magnetic resonance imaging clinics of North America.
[81] H. Alkadhi,et al. Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion. , 2012, Academic radiology.
[82] B. Seifert,et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. , 2014, Radiology.
[83] H. Rusinek,et al. Perfusion imaging of the liver: current challenges and future goals. , 2005, Radiology.
[84] M O Leach,et al. Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI. , 2007, The British journal of radiology.
[85] Jeong Min Lee,et al. Feasibility and accuracy of dual-source dual-energy CT for noninvasive determination of hepatic iron accumulation. , 2012, Radiology.
[86] Keiko Miyazaki,et al. Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response. , 2012, Radiology.
[87] S. Sironi,et al. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging , 2012, European Radiology.
[88] D. Collins,et al. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. , 2011, AJR. American journal of roentgenology.
[89] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[90] R Materne,et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. , 2001, AJR. American journal of roentgenology.
[91] Bachir Taouli,et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. , 2007, AJR. American journal of roentgenology.
[92] J. Cercueil,et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. , 2012, Radiology.
[93] C. Van de Wiele,et al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases , 2012, British Journal of Cancer.
[94] D. Hemingway,et al. Prospective assessment of the hepatic perfusion index in patients with colorectal cancer , 1998, The British journal of surgery.
[95] R. Jeffrey,et al. Antiangiogenic and Radiation Therapy: Early Effects on In Vivo Computed Tomography Perfusion Parameters in Human Colon Cancer Xenografts in Mice , 2012, Investigative radiology.
[96] Xiao-Ming Zhang,et al. Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma , 2012, Journal of computer assisted tomography.
[97] H. Huisman,et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging , 2012, European Radiology.
[98] L. Schwartz,et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[99] A. Gamst,et al. Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion‐weighted MRI measurements in adults , 2015, Journal of magnetic resonance imaging : JMRI.
[100] Marek Ancukiewicz,et al. Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy , 2013, Journal of Hematology & Oncology.
[101] Tao Jiang,et al. Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST) , 2012, Investigative radiology.
[102] Ke-min Chen,et al. Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging. , 2008, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[103] Jean-Luc Daire,et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.
[104] Alastair J. Martin,et al. Chronic hepatitis: Role of diffusion‐weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation , 2008, Journal of magnetic resonance imaging : JMRI.
[105] David Atkinson,et al. Optimizing functional parameter accuracy for breath-hold DCE-MRI of liver tumours , 2009, Physics in medicine and biology.
[106] R. O'Gorman,et al. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. , 2005, The British journal of radiology.
[107] M. Mack,et al. Tracer kinetics analysis of dynamic contrast‐enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results , 2009, Clinical physiology and functional imaging.
[108] R Sinnatamby,et al. In vivo assessment of neovascularization of liver metastases using perfusion CT. , 1998, The British journal of radiology.
[109] G. Frija,et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent , 2004, European Radiology.
[110] F Frouin,et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. , 2001, Radiology.
[111] Sabrina Fox‐Bosetti,et al. Test–retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C , 2011, Journal of magnetic resonance imaging : JMRI.
[112] U. Tateishi,et al. Pharmacokinetic parameters from 3‐Tesla DCE‐MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis , 2012, International journal of cancer.
[113] Y. Takeda,et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. , 2006, Oncology reports.
[114] M. Oudkerk,et al. Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver , 2014, PloS one.
[115] F. Fazio,et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. , 2010, World journal of gastroenterology.
[116] P. Burns,et al. The lognormal perfusion model for disruption replenishment measurements of blood flow: in vivo validation. , 2011, Ultrasound in medicine & biology.
[117] C. Tiribelli,et al. Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients. , 2003, Academic radiology.
[118] S. Koscielny,et al. Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography , 2010, Clinical Cancer Research.
[119] Jin-ping Li,et al. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.
[120] G. Baron,et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. , 2010, Radiology.
[121] B. V. Van Beers,et al. Assessment of diffusion‐weighted MR imaging in liver fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.
[122] S. Sourbron. Technical aspects of MR perfusion. , 2010, European journal of radiology.
[123] Marco Salvatore,et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.
[124] C. Thng,et al. Fundamentals of tracer kinetics for dynamic contrast‐enhanced MRI , 2011, Journal of magnetic resonance imaging : JMRI.
[125] S. Kumano,et al. Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.
[126] M Takahashi,et al. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. , 1997, Radiology.
[127] Xiao-Ming Yin,et al. Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography. , 2009, World journal of gastroenterology.
[128] F. Ridolfi,et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[129] Ralph Sinkus,et al. Hepatic viscoelastic parameters measured with MR elastography: Correlations with quantitative analysis of liver fibrosis in the rat , 2007, Journal of magnetic resonance imaging : JMRI.
[130] R. Loffroy,et al. Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization! , 2009, Journal of hepatology.
[131] F. Fazio,et al. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. , 2010, European journal of radiology.
[132] Thomas Henzler,et al. Contrast-Enhanced Dual-Energy CT of Gastrointestinal Stromal Tumors: Is Iodine-Related Attenuation a Potential Indicator of Tumor Response? , 2012, Investigative radiology.
[133] H. Alkadhi,et al. Quantification of liver iron content with CT—added value of dual-energy , 2011, European Radiology.
[134] T. Ichikawa,et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. , 1998, AJR. American journal of roentgenology.
[135] K. Kichikawa,et al. Early Detection of Therapeutic Response to Hepatic Arterial Infusion Chemotherapy of Liver Metastases from Colorectal Cancer Using Diffusion-Weighted MR Imaging , 2009, CardioVascular and Interventional Radiology.
[136] A Heerschap,et al. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium‐DTPA‐enhanced MRI and localized 19F MRS pharmacokinetic studies of 5‐fluorouracil , 2007, NMR in biomedicine.
[137] B. Bolster,et al. MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. , 2012, Academic radiology.
[138] Hyung Jin Won,et al. Assessment of Hepatic Function with Gd-EOB-DTPA-Enhanced Hepatic MRI , 2012, Digestive Diseases.
[139] C. V. van Kuijk,et al. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities. , 2010, Ultrasound in medicine & biology.
[140] David L Buckley,et al. Uncertainty in the analysis of tracer kinetics using dynamic contrast‐enhanced T1‐weighted MRI , 2002, Magnetic resonance in medicine.
[141] C. Zuiani,et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients , 2007, La radiologia medica.
[142] B. V. Van Beers,et al. Assessment of hepatic perfusion parameters with dynamic MRI , 2002, Magnetic resonance in medicine.
[143] C. Zuiani,et al. Relevance of b‐values in evaluating liver fibrosis: A study in healthy and cirrhotic subjects using two single‐shot spin‐echo echo‐planar diffusion‐weighted sequences , 2008, Journal of magnetic resonance imaging : JMRI.
[144] D. Collins,et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. , 2007, AJR. American journal of roentgenology.
[145] R. Ehman,et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. , 2011, Radiology.
[146] Ralph Sinkus,et al. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging , 2008, European Radiology.
[147] Wen He,et al. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. , 2008, World journal of gastroenterology.
[148] C. Muhle,et al. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases. , 1997, Investigative radiology.
[149] Stephanie R. Wilson,et al. New Noninvasive Ultrasound Techniques: Can They Predict Liver Cirrhosis? , 2012, Ultrasound quarterly.
[150] D. Collins,et al. Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor , 2008, European Radiology.
[151] Wei Wei,et al. Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy. , 2011, AJR. American journal of roentgenology.
[152] B. V. Van Beers,et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. , 2000, Clinical science.
[153] E. Hecht,et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. , 2008, Radiology.
[154] Christian Stroszczynski,et al. Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI , 2013, PloS one.
[155] P. Burns,et al. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. , 2001, Seminars in liver disease.
[156] H. Rusinek,et al. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast‐enhanced MRI alone and in combination: Preliminary experience , 2010, Journal of magnetic resonance imaging : JMRI.
[157] Chiun Hsu,et al. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. , 2011, Journal of hepatology.
[158] Thomas E Yankeelov,et al. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. , 2007, Current medical imaging reviews.
[159] M. Yin,et al. Cross-vendor validation of liver magnetic resonance elastography , 2015, Abdominal Imaging.
[160] B. V. Van Beers,et al. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. , 2003, Radiology.
[161] T-Y Lee,et al. CT imaging of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[162] C. Claussen,et al. Volume perfusion-CT of the liver: insights and applications. , 2012, European journal of radiology.
[163] H. Rusinek,et al. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. , 2009, Magnetic resonance imaging clinics of North America.
[164] M. P. Hayball,et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography , 2012, European Radiology.
[165] A. Padhani,et al. Diffusion MR imaging for monitoring of treatment response. , 2011, Magnetic resonance imaging clinics of North America.